Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells

In: Fertility and Sterility · 2009 · vol. 93(8) , pp. 2680–2686 · doi:10.1016/j.fertnstert.2009.08.056 · W2010965653
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-08-02

17beta-estradiol and 4-hydroxytamoxifen increased vascular endothelial growth factor and decreased soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells, while raloxifene had no significant effect.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo determine whether 17beta-estradiol (E(2)) and selective estrogen receptor modulators can regulate vascular endothelial growth factor (VEGF) and soluble VEGF receptor 1 (sVEGFR-1) as a VEGF antagonist in human endometrial stromal cells (ESCs).DesignIn vitro experiment.SettingResearch laboratory at Kansai Medical University.Patient(s)Sixteen patients undergoing hysterectomy for benign reasons.Intervention(s)The ESCs were cultured with E(2), 4-hydroxytamoxifen (OHT), and raloxifene.Main outcome measure(s)The VEGF and sVEGFR-1 messenger RNA (mRNA) levels in ESCs were determined using quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Free (unbound) VEGF and sVEGFR-1 protein levels from ESCs were measured using ELISA kits.Result(s)The E(2) significantly induced VEGF mRNA levels, whereas E2 caused a significant decrease in sVEGFR-1 messenger RNA (mRNA) levels. The E(2) or OHT significantly increased the VEGF production levels and attenuated the sVEGFR-1 production compared with control, but raloxifene had no significant effect. The decrease in levels of free VEGF was proportional to the increase in sVEGFR-1 levels in the culture media of ESCs.Conclusion(s)The E(2) or OHT stimulates VEGF production and concurrently attenuates sVEGFR-1 production in ESCs. This consequential increase in VEGF:sVEGFR-1 ratio might enhance the biological effects of VEGF on the angiogenic environment in human endometrium.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (46)

Cited by (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK